» Articles » PMID: 36827164

Inhibition of Polymicrobial Biofilms of -/ by Fucoidan-Gold Nanoparticles

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2023 Feb 24
PMID 36827164
Authors
Affiliations
Soon will be listed here.
Abstract

The polymicrobial proliferation and development of complex biofilm morphologies by bacterial and fungal pathogens in the host are some of the key factors contributing to the failure of antimicrobial treatments. The polymicrobial interaction of and some bacterial species has been extensively studied in both in vitro and in vivo model systems. Alternative strategies for disrupting polymicrobial interaction and biofilm formation are constantly needed. Among several alternative strategies, the use of nanoparticles synthesized using a natural product in the treatment of microbial infection has been considered a promising approach. The current study aimed to synthesize gold nanoparticles (AuNPs) using a natural product, fucoidan, and to test their efficacy against mono and duo combinations of fungal () and bacterial (/) biofilms. Several methods were used to characterize and study Fu-AuNPs, including UV-vis absorption spectroscopy, FTIR, FE-TEM, EDS, DLS, zeta potential, and XRD. The concentration-dependent inhibition of early-stage biofilms and the eradication of mature biofilms of single species of , , and have been observed. Early biofilms of a dual-species combination of and / were also suppressed at an increasing concentration of Fu-AuNPs. Furthermore, Fu-AuNPs significantly eradicated the established mature biofilm of mixed species. The treatment method proposed in this study, which involves the use of marine-bioinspired nanoparticles, is a promising and biocompatible agent for preventing the growth of polymicrobial biofilms of bacterial and fungal pathogens.

Citing Articles

Resveratrol-coated gold nanorods produced by green synthesis with activity against .

Fonseca Do Carmo P, Pinheiro Lage A, Garcia M, Da Silva N, Santos D, Mylonakis E Virulence. 2024; 15(1):2416550.

PMID: 39427236 PMC: 11492707. DOI: 10.1080/21505594.2024.2416550.


The progress and future of the treatment of Candida albicans infections based on nanotechnology.

Gao Y, Cao Q, Xiao Y, Wu Y, Ding L, Huang H J Nanobiotechnology. 2024; 22(1):568.

PMID: 39285480 PMC: 11406819. DOI: 10.1186/s12951-024-02841-6.


Effects of Sucrose and Farnesol on Biofilm Formation by and .

Wint W, Miyanohara M, Terada-Ito C, Yamada H, Ryo K, Murata T Microorganisms. 2024; 12(8).

PMID: 39203579 PMC: 11357214. DOI: 10.3390/microorganisms12081737.


"Stop, Little Pot" as the Motto of Suppressive Management of Various Microbial Consortia.

Efremenko E, Stepanov N, Senko O, Maslova O, Lyagin I, Domnin M Microorganisms. 2024; 12(8).

PMID: 39203492 PMC: 11356704. DOI: 10.3390/microorganisms12081650.


Medical Device-Associated Infections Caused by Biofilm-Forming Microbial Pathogens and Controlling Strategies.

Mishra A, Aggarwal A, Khan F Antibiotics (Basel). 2024; 13(7).

PMID: 39061305 PMC: 11274200. DOI: 10.3390/antibiotics13070623.


References
1.
OBrien T, Figueroa W, Welch M . Decreased efficacy of antimicrobial agents in a polymicrobial environment. ISME J. 2022; 16(7):1694-1704. PMC: 9213441. DOI: 10.1038/s41396-022-01218-7. View

2.
Jang H, Kang K, El-Sayed M . Facile size-controlled synthesis of fucoidan-coated gold nanoparticles and cooperative anticancer effect with doxorubicin. J Mater Chem B. 2020; 5(30):6147-6153. DOI: 10.1039/c7tb01123g. View

3.
Yokota T, Nomura K, Nagashima M, Kamimura N . Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression. J Nutr Biochem. 2016; 32:46-54. DOI: 10.1016/j.jnutbio.2016.01.011. View

4.
Wan M, Qin W, Lei C, Li Q, Meng M, Fang M . Biomaterials from the sea: Future building blocks for biomedical applications. Bioact Mater. 2021; 6(12):4255-4285. PMC: 8102716. DOI: 10.1016/j.bioactmat.2021.04.028. View

5.
Kong E, Tsui C, Kucharikova S, Andes D, Van Dijck P, Jabra-Rizk M . Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix. mBio. 2016; 7(5). PMC: 5061872. DOI: 10.1128/mBio.01365-16. View